As Flu Season Approaches, Prepare to Vaccinate This Fall
Drug Topics
AUGUST 30, 2022
This National Immunization Awareness Month, prepare your pharmacy to offer important vaccines.
Tue.Aug 30, 2022
187 
Study Shows Rates of Type 2 Diabetes in Children Rose During COVID-19 Pandemic
Pharmacy Times
AUGUST 30, 2022
Analysis from the Johns Hopkins Children’s Center and University of Colorado indicates that cancellation of sports and a switch to virtual learning likely increased this risk.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Patients Turning to Medical Cannabis for Menopause Relief
Drug Topics
AUGUST 30, 2022
More women are using medical cannabis for menopause-related symptoms.
Vaccination Coverage in Patients With Diabetes
Pharmacy Times
AUGUST 30, 2022
Hospitalization and interprofessional team management, particularly the involvement of a pharmacist, are essential in vaccination coverage for patients with diabetes.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Parexel joins pharmacy giants in quest to boost community health clinical trials
PharmaVoice
AUGUST 30, 2022
The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.
Pharmacy Focus: On The Shelf - Sunscreen Recommendations and the OTC Guide
Pharmacy Times
AUGUST 30, 2022
Joanna discusses her recommendations for sunscreen and what pharmacists picked as their favorite sunscreen product in the OTC Guide.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Pharmacy Focus: Student Edition - Learning to Be a Preceptor
Pharmacy Times
AUGUST 30, 2022
This month, we spoke with several interesting people in the pharmacy field, including the author of a children's book and hosts of a new podcast.
Certain Skin Diseases More Likely in Patients with Inflammatory Bowel Disease
Drug Topics
AUGUST 30, 2022
New research examines how often immune-mediated inflammatory skin diseases occur in patients with inflammatory bowel disease.
FDA Approves Abbott’s Proclaim Plus Spinal Cord Stimulation System
Pharmacy Times
AUGUST 30, 2022
Device provides tailored relief to multiple pain areas and adds more treatment options for evolving conditions.
A Collaborative Approach to Pediatric Vaccine Administration
Drug Topics
AUGUST 30, 2022
The panel provides strategic approaches to address pediatric vaccine schedules, with an emphasis on influenza vaccination.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Watch DSN: CVS Health’s Tony Clapsis highlights importance of clinical research
Drug Store News
AUGUST 30, 2022
In this latest installment of the Watch DSN video series, editor in chief Nigel Maynard, spoke with Tony Clapsis, senior vice president of Clinical Trial Services at CVS Health.
ESC22: Despite trial misses, Bayer preps phase 3 for asundexian
pharmaphorum
AUGUST 30, 2022
Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial programme will investigate the potential of asundexian in up to 30,000 patients with atrial fibrillation (AF) as well as patients with a non-cardioembolic ischaemic stroke or high-risk transient ischemic attack (TIA), said Bayer.
Great Strides Drive Progress Toward Precision Medicine in Lung Cancer Therapy
Pharmacy Times
AUGUST 30, 2022
Disease management is moving toward holistic care of the patient in the long term.
3D printing of starch-based tablets for personalised drug delivery
European Pharmaceutical Review
AUGUST 30, 2022
Researchers from UPV/EHU-University of the Basque Country, Spain, have successfully produced different types of starch-based pharmaceutical tablets using 3D printing. The aim of the study, published in the International Journal of Pharmaceutics , was to produce 3D printed starch-based tablets for the tailored delivery of hydrophobic drugs. Hydrophobic drugs – those that poorly water soluble – account for some 40% of marketed drugs and the 60% of the drug candidates in research, the paper notes.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The importance of microbiology publications
Pharmig
AUGUST 30, 2022
The purpose of a professional pharmaceutical microbiology organisation such as Pharmig is to ensure that we are representing the individuals who work in microbiology in healthcare settings, pharmaceutical and NHS industries. The post The importance of microbiology publications appeared first on Pharmig.
Moderna’s lawsuit against Pfizer and BioNTech explained in 10 quotes
PharmaVoice
AUGUST 30, 2022
The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.
Florence Healthcare helps empower retailers involved in clinical trials
Drug Store News
AUGUST 30, 2022
Gunnar Esiason spoke with DSN about how the company’s software platform is enabling retailers to eliminate inefficiencies in clinical trial management.
Europe approves first gene therapy for treatment of haemophilia A
European Pharmaceutical Review
AUGUST 30, 2022
The European Commission has granted conditional marketing authorization to BioMarin’s ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe haemophilia A in adult patients without a history of Factor VIII inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (AAV5). The EC also endorsed the European Medicines Agency’s (EMA’s) recommendation for Roctavian to maintain orphan drug designation, thereby granting a 10-year period of market ex
Walgreens Boots Alliance acquires CareCentrix
Drug Store News
AUGUST 30, 2022
WBA's partnership with CareCentrix extends care capabilities into the home to create a connected ecosystem for patients, the company said.
EnACT patient-centric design in digital health development
pharmaphorum
AUGUST 30, 2022
New practical guide walks digital health entrepreneurs through the patient and public involvement and engagement process. . Digital transformation could revolutionise healthcare, making for happier, healthier populations – but only if solutions are designed and deployed with patients at the heart. . That’s why a newly published, evidence-based guide for digital innovators, from the Academic Health Science Networks (AHSN) Network, the University of Plymouth, and Boehringer Ingelheim, aims to s
Giant Food names SVP of operations
Drug Store News
AUGUST 30, 2022
Diane Hicks will oversee omnichannel store operations, store support, asset protection, pharmacy and store development.
Black participants make up just 3% in cancer clinical trials, says GlobalData
European Pharmaceutical Review
AUGUST 30, 2022
Diversity within the pharmaceutical sector and clinical trials continues to be a problem, according to a recent report by data and analytics company GlobalData. The report, Clinical Trials – The Importance of Diversity in Clinical Trials , examined data from clinical trials initiated between 1 January 2013 and 16 June 2022. Disclosed racial representation data was analysed by location, year, trial phase, therapy area, among other factors.
Daily Medication Pearl: Tranexamic Acid
Pharmacy Times
AUGUST 30, 2022
Tranexamic acid indicated for patients with hemophilia for short-term use to reduce or prevent hemorrhage and decrease the need for replacement therapy during and following tooth extraction.
Hy-Vee set to host quarterly Best of Local Brands summit
Drug Store News
AUGUST 30, 2022
Vendors are invited to submit their products for potential Hy-Vee distribution.
Amgen Announces Positive Data for ABP959, Biosimilar Candidate to Soliris
Pharmacy Times
AUGUST 30, 2022
Study evaluates efficacy, immunogenicity, safety of the product to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
ESC22: AstraZeneca’s Farxiga DELIVERs in heart failure
pharmaphorum
AUGUST 30, 2022
AstraZeneca’s Farxiga reduced the risk of hospitalisation and death in people with all types of heart failure in the DELIVER trial, which could dramatically increase the population of patients eligible for treatment with the SGLT2 inhibitor. The study showed that treatment with Farxiga (dapagliflozin) reduced led to an 18% reduction in cardiovascular death or worsening heart failure in patients with both mildly reduced and preserved ejection fraction, said AZ.
Lung Cancer Patients Show Better Overall Survival With Atezolizumab in Clinical Trial
Pharmacy Times
AUGUST 30, 2022
Atezolizumab meets its primary endpoint of overall survival for patients with resected non-small cell lung cancer across most subgroups.
Charles River opens research facilities in California and Washington
Outsourcing Pharma
AUGUST 30, 2022
Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.
Emerging Therapies Are Changing the Melanoma Treatment Landscape
Pharmacy Times
AUGUST 30, 2022
Specialty pharmacists play critical role in supporting treatment adherence.
Review finds greater regular physical activity lowers risk of adverse COVID-19 outcomes
Hospital Pharmacy Europe
AUGUST 30, 2022
Greater regular physical activity is protective against infection, hospitalisation and death among those infected with COVID-19. Greater regular physical activity results in a reduced risk of infection, hospitalisation, severe illness and mortality from COVID-19 in comparison to those who are inactive according to the findings of a systematic review and meta-analysis by a team of Spanish researchers.
OTC Hearing Aids
Oswald's
AUGUST 30, 2022
Losing hearing later in life is difficult but getting the hearing aids you need is easier than ever. Hearing Aid technology has advanced by leaps and bounds over the past 20 years, allowing for some truly amazing ways to get great hearing aids. How is this possible? A recent FDA ruling allowed for the sale… The post OTC Hearing Aids appeared first on Oswald's Pharmacy.
RSVpreF vaccine candidate effective against respiratory syncytial virus
Hospital Pharmacy Europe
AUGUST 30, 2022
RSVpreF, a vaccine candidate against respiratory syncytial virus, appears to be very effective for older adults with more severe infection. Pfizer’s vaccine candidate RSVpreF for respiratory syncytial virus (RSV) showed a high level of efficacy in older patients with more severe lower respiratory tract illness which was defined by three or more RSV-associated symptoms according to a press release from the company.
FDA accepts Sanofi’s haemophilia A treatment BLA for priority review
Pharmaceutical Technology
AUGUST 30, 2022
The US Food and Drug Administration (FDA) has accepted Sanofi ’s efanesoctocog alfa (BIVV001) Biologics License Application (BLA), to treat haemophilia A, for priority review. A decision from the regulatory agency on approval for the therapy is anticipated on 28 February next year. The application is based on findings from the open-label, non-randomised, interventional Phase III XTEND-1 clinical trial designed to evaluate the safety, efficacy and pharmacokinetics of efanesoctocog alfa given once
Intensity-modulated radiation therapy effective without chemotherapy in nasopharyngeal cancer
Hospital Pharmacy Europe
AUGUST 30, 2022
Intensity-modulated radiation mono-therapy is equivalent to chemo-radiotherapy in patients with low-risk nasopharyngeal cancer. Intensity-modulated radiation mono-therapy (IMRT) for patients with stage II nasopharyngeal cancer provides a similar level of 3-year estimated survival as cisplatin chemoradiotherapy according to a randomised trial by Chinese researchers.
Let's personalize your content